Clinical Trial Update: AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

View source ↗

Summary

A completed clinical trial evaluating AggreGuide 325 mg aspirin for aspirin-induced platelet dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Platelet Function

Drugs mentioned

• AggreGuide 325 mg (Aspirin)

Snippet

Sponsor: Aggredyne, Inc. | Conditions: Platelet Dysfunction Due to Aspirin Ingestion | Status: COMPLETED